Korea Asset Investment Securities logo

Korea Asset Investment Securities

Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo

Description

Korea Asset Investment Securities is a securities brokerage company.

Investor Profile

Korea Asset Investment Securities has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Post Ipo Equity (33%)

Country Focus

  • South Korea (67%)
  • United States (33%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Manufacturing
  • Navigation
  • Robotics
  • Finance
  • Financial Services
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Korea Asset Investment Securities frequently co-invest with?

SC
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
JX Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Capstone Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Evergreen Investment Partners
Europe, Nordrhein-Westfalen, Germany, England
Co-Investments: 1
JB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
VB
North America, Nevada, United States, Incline Village
Co-Investments: 1
Kingo Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Hyundai Venture Investment Corporation
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Hi Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Seoul Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Korea Asset Investment Securities?

Polaris3D

Pohang, Kyongsang-bukto, South Korea

Polaris3d offers indoor autonomous navigating solution.

NavigationRobotics
Series BJun 3, 2024
Amount Raised: $10,934,619
Nine Biopharm

Suwon, Ch'ungch'ong-namdo, South Korea

Nine Biopharm is biotechnology company that develops new peptidomimetic materials, compound new materials, and drug repositioning.

BiopharmaBiotechnologyManufacturing
Series ADec 21, 2021
Amount Raised: $6,715,099
Perella Weinberg

New York, New York, United States

Perella Weinberg is a privately-owned financial services firm that provides corporate advisory and asset management services.

FinanceFinancial Services
Post Ipo EquityJun 25, 2021
Amount Raised: $125,000,000